阴道微生物群、人乳头瘤病毒与宫颈异型增生:系统综述与网状Meta分析
该系统综述与网状Meta分析纳入基于分子技术鉴定细菌群落状态类型(CST)并报告与HPV感染、宫颈异型增生和/或宫颈癌关联的原始研究,检索PubMed、Web of Science、Embase和Cochrane数据库。结果显示,以非乳杆菌物种或惰性乳杆菌(Lactobacillus iners)为主的阴道微生物群,与以卷曲乳杆菌(Lactobacillus crispatus)为主相比,任何现患HPV的比值比高3至5倍,高危HPV和异型增生/宫颈癌的比值比高2至3倍。作者认为特定细菌群落类型与HPV感染及HPV相关疾病存在关联。
要点
- 以非乳杆菌或惰性乳杆菌为主的阴道菌群与任何现患HPV的比值比,是以卷曲乳杆菌为主者的3至5倍。
- 上述菌群与高危HPV及宫颈异型增生/宫颈癌的比值比,是以卷曲乳杆菌为主者的2至3倍。
- 作者认为该关联可能有助于指导治疗选择或作为HPV相关疾病的生物标志物。
核心结论
- 特定阴道细菌群落类型与HPV感染及HPV相关疾病存在关联,可能有助于指导治疗选择或作为HPV相关疾病的生物标志物。
研究设计与样本
- 系统综述与网状Meta分析,已在PROSPERO注册(CRD42018112862)。
- 检索PubMed、Web of Science、Embase和Cochrane数据库。
- 纳入标准为所有基于分子技术鉴定细菌并描述至少两种细菌群落状态类型(CST)、报告与HPV感染、宫颈异型增生和/或宫颈癌关联的原始研究。
主要发现
- 以非乳杆菌物种或惰性乳杆菌(Lactobacillus iners)为主的阴道微生物群,与以卷曲乳杆菌(Lactobacillus crispatus)为主相比,任何现患HPV的比值比高3至5倍。
- 以非乳杆菌物种或惰性乳杆菌为主的阴道微生物群,与以卷曲乳杆菌为主相比,高危HPV和异型增生/宫颈癌的比值比高2至3倍。
临床怎么用
- 作者认为这些发现提示特定阴道细菌群落类型与HPV感染及HPV相关疾病存在关联,可能有助于指导治疗选择或作为HPV相关疾病的生物标志物。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Persistent infection with high-risk human papillomavirus can lead to cervical dysplasia and cancer. Recent studies have suggested associations between the composition of the vaginal microbiota, infection with human papillomavirus (HPV) and progression to cervical dysplasia and cancer. OBJECTIVE: To assess how specific cervico-vaginal microbiota compositions are associated with HPV infection, cervical dysplasia and cancer, we conducted a systematic review and network meta-analysis (registered in PROSPERO: CRD42018112862). SEARCH STRATEGY: PubMed, Web of science, Embase and Cochrane database. SELECTION CRITERIA: All original studies describing at least two community state types of bacteria (CST), based on molecular techniques enabling identification of bacteria, and reporting the association with HPV infection, cervical dysplasia and/or cervical cancer. DATA COLLECTION AND ANALYSIS: For the meta-analysis, a network map was constructed to provide an overview of the network relationships and to assess how many studies provided direct evidence for the different vaginal microbiota compositions and HPV, cervical dysplasia or cancer. Thereafter, the consistency of the model was assessed, and forest plots were constructed to pool and summarise the available evidence, presenting odds ratios and 95% confidence intervals. MAIN RESULTS: Vaginal microbiota dominated by non-Lactobacilli species or Lactobacillus iners were associated with three to five times higher odds of any prevalent HPV and two to three times higher for high-risk HPV and dysplasia/cervical cancer compared with Lactobacillus crispatus. CONCLUSIONS: These findings suggest an association between certain bacterial community types of the vaginal microbiota and HPV infection and HPV-related disease. This may be useful for guiding treatment options or serve as biomarkers for HPV-related disease. TWEETABLE ABSTRACT: This network meta-analysis suggests an association between different vaginal bacterial community types and the risk of HPV.
引用
- Norenhag J, Du J, Olovsson M, et al. The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analysis. BJOG. 2019. PMID: 31237400. doi:10.1111/1471-0528.15854
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。